Millennium Management »

An2 Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.1M 526k 2.15
2024-03-31 $315k 97k 3.25
2023-12-31 $813k 40k 20.49
2023-06-30 $206k 24k 8.50
2022-03-31 $1.1M 74k 15.07

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
NVIDIA Corporation Put Option (NVDA)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation Put Option (MSFT)
Amazon Put Option (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Tesla Motors (TSLA)
Broadcom Put Option (AVGO)
Ishares Tr Msci Emg Mkt Etf (EEM)
Advanced Micro Devices Put Option (AMD)
Merck & Co Call Option (MRK)

View all positions for Millennium Management

Top funds holding An2 Therapeutics

RA Capital Management
Octagon Capital Advisors
Frazier Life Sciences Management
TCG Crossover Management
Citadel Advisors
Henderson Group
Vanguard Group
Millennium Management
Adage Capital Partners GP
BlackRock
Goldman Sachs Group
Ghost Tree Capital
Geode Capital Management
Two Sigma Advisers
Walleye Trading Advisors

View all funds holding An2 Therapeutics